Farthing C et al. |
Azithromycin for cerebral toxoplasmosis. |
1992 |
Lancet |
pmid:1346707
|
Chave JP et al. |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324635
|
Derouin F et al. |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324642
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Pajukanta R et al. |
In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329617
|
Bonnet M and Van der Auwera P |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329619
|
Pruul H and McDonald PJ |
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317141
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Kobrehel G et al. |
Synthesis and antibacterial activity of O-methylazithromycin derivatives. |
1992 |
J. Antibiot. |
pmid:1317368
|
Welsh LE et al. |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1318677
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Drew RH and Gallis HA |
Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. |
1992 |
Pharmacotherapy |
pmid:1319048
|
Frank MO et al. |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336337
|
O'Reilly T et al. |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336342
|
Lazarova Z et al. |
Azithromycin (Sumamed-Pliva) in the treatment of chlamydial genital tract infections in infertile marriages. |
1992 Nov-Dec |
Int J STD AIDS |
pmid:1337473
|
Weiss LM et al. |
Efficacy of azithromycin for treating Babesia microti infection in the hamster model. |
1993 |
J. Infect. Dis. |
pmid:8228366
|
Lefèvre JC et al. |
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. |
1993 |
Pathol. Biol. |
pmid:8233628
|
Agacfidan A et al. |
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239579
|
Tomazic J et al. |
In vivo administration of azithromycin affects lymphocyte activity in vitro. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239585
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|